PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
OPRA vs. IMOS
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between OPRA and IMOS is 0.19, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.2

Performance

OPRA vs. IMOS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Opera Limited (OPRA) and ChipMOS TECHNOLOGIES INC. (IMOS). The values are adjusted to include any dividend payments, if applicable.

-20.00%0.00%20.00%40.00%60.00%80.00%SeptemberOctoberNovemberDecember2025February
69.83%
-10.42%
OPRA
IMOS

Key characteristics

Sharpe Ratio

OPRA:

1.63

IMOS:

-0.78

Sortino Ratio

OPRA:

2.52

IMOS:

-1.01

Omega Ratio

OPRA:

1.29

IMOS:

0.88

Calmar Ratio

OPRA:

1.46

IMOS:

-0.46

Martin Ratio

OPRA:

7.02

IMOS:

-0.94

Ulcer Index

OPRA:

12.61%

IMOS:

25.11%

Daily Std Dev

OPRA:

54.31%

IMOS:

30.38%

Max Drawdown

OPRA:

-72.85%

IMOS:

-98.76%

Current Drawdown

OPRA:

-16.80%

IMOS:

-42.99%

Fundamentals

Market Cap

OPRA:

$1.89B

IMOS:

$753.06M

EPS

OPRA:

$1.80

IMOS:

$1.49

PE Ratio

OPRA:

11.87

IMOS:

13.90

Total Revenue (TTM)

OPRA:

$347.75M

IMOS:

$17.30B

Gross Profit (TTM)

OPRA:

$182.52M

IMOS:

$2.43B

EBITDA (TTM)

OPRA:

$184.21M

IMOS:

$4.71B

Returns By Period

In the year-to-date period, OPRA achieves a 15.13% return, which is significantly higher than IMOS's 9.98% return.


OPRA

YTD

15.13%

1M

16.85%

6M

69.83%

1Y

104.51%

5Y*

31.28%

10Y*

N/A

IMOS

YTD

9.98%

1M

13.54%

6M

-10.42%

1Y

-22.59%

5Y*

6.46%

10Y*

7.68%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

OPRA vs. IMOS — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

OPRA
The Risk-Adjusted Performance Rank of OPRA is 8585
Overall Rank
The Sharpe Ratio Rank of OPRA is 8888
Sharpe Ratio Rank
The Sortino Ratio Rank of OPRA is 8686
Sortino Ratio Rank
The Omega Ratio Rank of OPRA is 8181
Omega Ratio Rank
The Calmar Ratio Rank of OPRA is 8585
Calmar Ratio Rank
The Martin Ratio Rank of OPRA is 8686
Martin Ratio Rank

IMOS
The Risk-Adjusted Performance Rank of IMOS is 1515
Overall Rank
The Sharpe Ratio Rank of IMOS is 99
Sharpe Ratio Rank
The Sortino Ratio Rank of IMOS is 1010
Sortino Ratio Rank
The Omega Ratio Rank of IMOS is 1111
Omega Ratio Rank
The Calmar Ratio Rank of IMOS is 1919
Calmar Ratio Rank
The Martin Ratio Rank of IMOS is 2424
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

OPRA vs. IMOS - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Opera Limited (OPRA) and ChipMOS TECHNOLOGIES INC. (IMOS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for OPRA, currently valued at 1.63, compared to the broader market-2.000.002.001.63-0.78
The chart of Sortino ratio for OPRA, currently valued at 2.52, compared to the broader market-4.00-2.000.002.004.006.002.52-1.01
The chart of Omega ratio for OPRA, currently valued at 1.29, compared to the broader market0.501.001.502.001.290.88
The chart of Calmar ratio for OPRA, currently valued at 1.46, compared to the broader market0.002.004.006.001.46-0.46
The chart of Martin ratio for OPRA, currently valued at 7.02, compared to the broader market0.0010.0020.0030.007.02-0.94
OPRA
IMOS

The current OPRA Sharpe Ratio is 1.63, which is higher than the IMOS Sharpe Ratio of -0.78. The chart below compares the historical Sharpe Ratios of OPRA and IMOS, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.50-1.00-0.500.000.501.001.502.00SeptemberOctoberNovemberDecember2025February
1.63
-0.78
OPRA
IMOS

Dividends

OPRA vs. IMOS - Dividend Comparison

OPRA's dividend yield for the trailing twelve months is around 3.75%, less than IMOS's 5.37% yield.


TTM20242023202220212020201920182017201620152014
OPRA
Opera Limited
3.75%4.22%9.07%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
IMOS
ChipMOS TECHNOLOGIES INC.
5.37%5.91%5.52%13.62%4.46%4.97%3.42%7.11%1.13%35.57%0.83%0.60%

Drawdowns

OPRA vs. IMOS - Drawdown Comparison

The maximum OPRA drawdown since its inception was -72.85%, smaller than the maximum IMOS drawdown of -98.76%. Use the drawdown chart below to compare losses from any high point for OPRA and IMOS. For additional features, visit the drawdowns tool.


-50.00%-40.00%-30.00%-20.00%-10.00%SeptemberOctoberNovemberDecember2025February
-16.80%
-42.99%
OPRA
IMOS

Volatility

OPRA vs. IMOS - Volatility Comparison

Opera Limited (OPRA) has a higher volatility of 16.75% compared to ChipMOS TECHNOLOGIES INC. (IMOS) at 14.08%. This indicates that OPRA's price experiences larger fluctuations and is considered to be riskier than IMOS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%20.00%SeptemberOctoberNovemberDecember2025February
16.75%
14.08%
OPRA
IMOS

Financials

OPRA vs. IMOS - Financials Comparison

This section allows you to compare key financial metrics between Opera Limited and ChipMOS TECHNOLOGIES INC.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab